07Nov 2022
Loss of bisecting GlcNAcylation on MCAM of bone marrow stoma determined pro-tumoral niche in MDS/AML

Loss of bisecting GlcNAcylation on MCAM of bone marrow stoma determined pro-tumoral niche in MDS/AML

Bone marrow (BM) stroma supports growth in hematopoietic stem cells (HSC). Glycosylation contributes to the interactions between HSC and the surrounding microenvironment. This study observed that bisecting N-acetylglucosamine (GlcNAc) structures in BM stromal cells were significantly lower for MDS/AML patients than for healthy subjects. Malignant clonal cells delivered exosomal miR-188-5p to recipient stromal cells, which suppressed bisecting GlcNAc by targeting the MGAT3 gene. Proteomic analysis revealed reduced GlcNAc structures and enhanced expression of MCAM, a marker of the BM niche. This study's findings suggest a novel mechanism whereby MDS/AML clonal cells generate a self-permissive place by modifying the glycosylation level of stromal cells.

  • #oncology

Like

Save

Share